RedChip

The World Leader in Small-Cap Investor Relations.
This is not investment advice. Full disclosures:

[RedChip @RedChip]

Featured in RedChip Investor Overview: Nord Precious Metals CEO Frank Bassa on Advancing a Historic High-Grade Silver Camp in Ontario

CEO and metallurgical engineer Frank Bassa outlines Nord Precious Metals' district-scale position in a former high-grade silver camp in Northern Ontario, where rising silver and critical metals prices are turning previously uneconomic material into ore. Bassa points to Ontario's streamlined 80-day production permitting as a key advantage for junior developers.

The company is pursuing a two-track strategy: reprocessing historical tailings from a recently acquired asset expected to yield a minimum of 2 million recoverable ounces of silver over seven years, alongside a fully funded 30,000-meter exploration drill program targeting resource expansion across wide, historically productive veins.

Watch the full overview: https://t.co/YEyA9PwN1P

Nord Precious Metals is a client of RedChip. Not investment advice. Do your own due diligence.

$MP $PPTA $TECK $KGC $USGO $HL $NST $CTGO $XAU $XAUUSD

[RedChip @RedChip]

Featured in RedChip Investor Webinar: Noble Africa CEO Paul Mann on a One-of-a-Kind Helium Reserve

CEO Paul Mann explains how this South African field formed from an asteroid impact two billion years ago, concentrating helium at roughly 3%, about 10 times higher than typical deposits elsewhere in the world. He notes it gives the company the lowest-cost path to new helium supply globally.

Watch the full webinar: https://t.co/V0QuTX3H9m

Noble Africa is a client of RedChip. Not investment advice. Do your own due diligence.

$SMR $NNE $OKLO $UUUU $CEG $VST $CCJ $UEC $LEU $GEV $BEP

[RedChip @RedChip]

Now on RedChip's Company Overview Series! Hawkeye Digital (OTC: HWKE) president David Wachsman lays out the company's pitch in under a minute: skip the token speculation, buy equity in the crypto businesses that already generate revenue. On the private equity side, Hawkeye invests in digital asset companies that have hit product-market fit and helps them expand geographically, build out their tech stack, and add new licenses. On the merchant banking side, Hawkeye takes minority stakes and guides companies through the capital markets process. Wachsman's framing: this is access to the infrastructure quietly repiping and rewiring Wall Street — not another crypto price bet.

▶️ Watch the overview: https://t.co/7Z43sgHhNz

Hawkeye Digital is a client of RedChip. Not investment advice. Do your own due diligence.

$MSTR $MARA $COIN

#DigitalAssets #Crypto #Blockchain #MerchantBanking #PrivateEquity #OTCMarkets #FinTech #WallStreet

[RedChip @RedChip]

Dr. Canaan Van Williams, CEO of Proactive Sustainable Bonds, said on RedChip's weekly TV show that the organization's strategy centers on renovating and improving occupied properties to bring units to market faster while preserving affordability for residents.

The US affordable housing shortage is measured in the millions of units, a gap Williams says has been building for decades regardless of economic cycle.

👉 Learn more at https://t.co/Xhov7hiXoI

Proactive Sustainable Bonds is a client of RedChip. Not investment advice. Do your own due diligence.

#PSB #ProactiveSustainableBonds #AffordableHousing #ImpactInvesting #RealEstateInvesting #WorkforceHousing #InvestorWebinar

[RedChip @RedChip]

RedChip recently spoke with CFO Brett Young of Clinch Resources (TSX: CLCH), who discussed the company's transition from a decade of development into a near-term cash-flowing metallurgical coal producer.

Young discussed the company's resource base at its flagship ARI project in West Virginia, including measured, indicated, and proven and probable reserves. He covered the company's projected life-of-mine cash costs, its production ramp-up timeline, and the potential financial outlook at current forward pricing. He also discussed met coal's 2025 designation as a U.S. critical mineral, and the company's existing infrastructure, including an operational wash plant and rail load-out, supporting its transition toward production.

Watch the full interview: https://t.co/opwS6S1aQu

Clinch Resources is a client of RedChip. Not investment advice. Do your own due diligence.

$CEIX $NRP $SXC $BHP $TECK $CLF $NUE $STLD $MT $RS $VALE $FCX $ARLP

[RedChip @RedChip]

RedChip's 30-second investor overview covers New Horizon Aircraft (Nasdaq: HOVR) and its hybrid-electric VTOL platform. Morgan Stanley has projected the vertical takeoff and landing aircraft market could reach $1T by 2040.

The overview covers New Horizon's Cavorite X7, which is designed for mission-critical markets including defense, medevac, disaster response, organ transport, and regional mobility.

Watch our 30-second investor brief on New Horizon Aircraft: https://t.co/OPUwK1IrCV

New Horizon Aircraft is a client of RedChip. Not investment advice. Do your own due diligence.

$LMT $RTX $BA $TXT

[RedChip @RedChip]

Featured in RedChip Investor Interview: Virax Biolabs (Nasdaq: VRAX) CEO James Foster on Fiscal 2026 Progress and What's Next

In this new interview, CEO James Foster walks through the company's fiscal 2026 shareholder update — including a strengthened balance sheet, regained Nasdaq compliance, and a new commercial supply agreement with Fosun Diagnostics covering six Southeast Asian markets, initially focused on tuberculosis-related research.

Foster also breaks down the difference between the company's two core programs: Immune Select, a research-use-only product line offering a nearer-term path to orders and revenue, and ViraxImmune, the in-development diagnostic platform targeting post-acute infection syndromes including long COVID.

Looking ahead, Foster outlines three catalysts for shareholders to watch: commercial execution on the Fosun agreement, clinical validation progress for ViraxImmune, and new strategic partnerships.

Watch the full interview: https://t.co/CWJfsDFhch

Virax Biolabs is a client of RedChip. Not investment advice. Do your own due diligence.

$VRTX $LLY $NVO $PFE $REGN $JNJ

[RedChip @RedChip]

On RedChips's recent webinar, Executive Chairman Bruce Ogilvie and CEO Jeff Walker talked about how they took Alliance Entertainment to $1.4 billion in 2020, funded entirely through bank debt, no private equity, no share dilution.

Watch the whole webinar: https://t.co/8YWPTZSE2K

Alliance Entertainment is a client of RedChip. Not investment advice. Do your own due diligence.

$AENT $FNKO $SONY $DIS $PARA $WBD $NTDOY

[RedChip @RedChip]

🧠 For over 50 years, levodopa has been the standard of care for Parkinson's — but according to BioVie (Nasdaq: BIVI) CEO Kong Do, it only addresses motor symptoms.

It doesn't touch the underlying disease progression, so the condition keeps advancing even on treatment.

📊 BioVie believes bezisterim could be the first new approach since levodopa to actually target that underlying driver — not just manage symptoms.

🔬 Full webinar replay: https://t.co/gQGHpk1Tmv

BioVie Inc. is a client of RedChip. Not investment advice. Do your own due diligence.

$VRTX $LLY $NVO $PFE $REGN

[RedChip @RedChip]

Recently on RedChip's Webinar Series: NioCorp Developments (Nasdaq: NB) CEO Mark Smith breaks down a pricing gap he says is drawing growing attention in the critical minerals market.

Smith states that scandium produced and sold within China currently runs roughly $800–$850 per kilogram, while scandium sold outside China trades between $3,000 and $6,500 per kilogram. He describes this as part of a broader bifurcation between Chinese and non-Chinese pricing across critical minerals, citing similar gaps in terbium and dysprosium, and says he expects the pattern to persist given how long it takes new non-Chinese supply projects to come online — reinforced, in his view, by Section 232 tariff authority and ongoing G7 pricing support discussions.

🔗 Learn more about NioCorp Developments: https://t.co/r92S6wDeYQ

NioCorp Developments is a client of RedChip. Not investment advice. Do your own due diligence.

$MP $PPTA $TECK $KGC $HL $NST $CTGO

[RedChip @RedChip]

RedChip's 30-second overview covers Exyn Technologies (Nasdaq: EXYN) and its ExynAI autonomous robotics platform.

The overview covers Exyn's Level 4B autonomy software, which is designed to let drones navigate underground mines, collapsed tunnels, and other GPS-denied environments without prior maps or a human at the controls. The company's customer base includes global mining operators, the U.S. Special Operations Command, and the U.S. Air Force.

Watch now: https://t.co/ma5RtN9CQV

Exyn Technologies is a client of RedChip. Not investment advice. Do your own due diligence.

$AVAV $TRMB $TDY $KTOS $OUST $UMAC

[RedChip @RedChip]

RedChip Overview: OBOOK Holdings' Regulated Stablecoin Infrastructure

Global payments are projected to surpass $3T, and RedChip produced an overview of OBOOK Holdings (OwlTing Group; Nasdaq: OWLS) and its work building compliant infrastructure to move value across borders using regulated stablecoins.

The overview covers OwlTing's regulated payment rails and the company's positioning as it works to scale utilization across its platform.

Watch our brief overview: https://t.co/eEqSOud7Vi

OBOOK Holdings is a client of RedChip. Not investment advice. Do your own due diligence.

$COIN $PYPL $XYZ $NATL $MARA $RIOT $MSTR $NVDA

[RedChip @RedChip]

RedChip spoke with CEO Chris Gerteisen of Nova Minerals (NYSE American: NVA), who discussed the company's two-track growth strategy in Alaska.

Gerteisen discussed the company's $43.4M in U.S. Department of War funding to build a domestic antimony supply chain, targeting military-spec production by 2026/27, alongside the company's large-scale gold development work. He covered the company's execution timelines and near-term milestones across both programs.

Watch our full interview: https://t.co/qrONLinJlI

Nova Minerals is a client of RedChip. Not investment advice. Do your own due diligence.

$MP $PPTA $TECK $KGC $HL $NST $CTGO $XAU $XAUUSD

[RedChip @RedChip]

🧠 In this overview, Nexalin Technology (Nasdaq: NXL) CEO Mark White lays out Nexalin's core bet: that the current medication isn't the only option, and that non-invasive brain stimulation can match it without the side effect profile.

White describes the underlying technology as a recreation of the brain's own natural electrical signal, delivered through microprocessors rather than drugs. He states the treatment runs an 80-90% response rate, with no physical or mental sensation during treatment.

The delivery model is built around Nexalin's wearable Halo headset: patients receive it at home, scan a QR code, download an app, and get their treatment protocol pushed from the cloud to the headset.

A doctor monitors remotely and no in-person visits required for ongoing care.

🔗 Watch the overview: https://t.co/vXUSGCBt9v

Nexalin Technology is a client of RedChip. Not investment advice. Do your own due diligence.

$VRTX $LLY $AMGN $REGN $GILD $MRNA

[RedChip @RedChip]

VENU Holding Corp. (NYSE American: VENU) CEO JW Roth breaks down why municipalities actively compete to land VENU projects.

Roth explains that every VENU project is structured as a partnership with the municipality, which contributes real estate, cash, and tax incentives — financing he says is non-dilutive to shareholders. He states the arrangement works both ways: VENU's venues bring an economic impact to the surrounding area, driving activity for restaurants and hospitality businesses nearby, which he calls a tax driver for the city.

🔗 Watch the clip: https://t.co/YegMc2Rpvy

VENU Holding Corp. is a client of RedChip. Not investment advice. Do your own due diligence.

$TKO $MSGE $LYV $SPHR

[RedChip @RedChip]

Featured in RedChip Investor Interview: TransCode Therapeutics (Nasdaq: RNAZ)

TransCode's CEO lays out the company's new corporate strategy: a three-platform oncology business spanning RNA therapeutics, cancer vaccines, and immuno-oncology, built out through the recent acquisition of a preclinical oncology company and licensing of an immunology pipeline.

Watch the full interview to hear how the three-platform approach is meant to create multiple paths to value.

👉 https://t.co/kEU21MecMG

TransCode Therapeutics is a client of RedChip. Not investment advice. Do your own due diligence.

$MRNA $ARWR $ALNY $IONS $SLN $SRPT

[RedChip @RedChip]

RedChip Exclusive Interview with Bimergen Energy (NYSE-A: BESS): Co-CEO Bob Brilon Breaks Down Bimergen's Backing, BESS Pipeline, and Scalable Growth Strategy

Utility-scale battery storage is one of the fastest-growing segments in energy, and @BimergenEnergy is stepping up with a 2GW pipeline, equity commitment, and contract-backed revenue model.

Watch our full interview now: https://t.co/LzAG5VG9PR

Bimergen Energy is a client of RedChip. Not investment advice. Do your own due diligence.

$NEE $FLNC $BE $ENPH $TSLA $GNRC

[RedChip @RedChip]

RedChip Overview: ASP Isotopes' Critical Materials Growth Strategy — ASP Isotopes (Nasdaq: ASPI) is targeting critical supply chains including nuclear medicine, nuclear fuel, semiconductors, and advanced materials. RedChip produced an overview featuring CEO Paul Mann, who discussed the company's growth strategy.

What was covered:
- The company's build-out of three plants in South Africa over three years
- An expected commercial ramp in 2026
- A U.S. expansion strategy aimed at securing supply chains historically sourced from Russia
- The company's positioning across multiple end markets with geopolitical relevance

Watch our full ASPI investor overview: https://t.co/gBlueK0Qpu

ASP Isotopes is a client of RedChip. Not investment advice. Do your own due diligence.

$SMR $NNE $OKLO $UUUU $CEG $VST $CCJ $UEC $LEU $GEV $BEP

[RedChip @RedChip]

Where does Amazon get the copper to build its AI data centers? Meet Gunnison Copper (TSX: GCU) (OTCQB: GCUMF) one of its newest suppliers...

This week, Interior Secretary Doug Burgum and Congressman Juan Ciscomani [AZ] visited Gunnison's Johnson Camp mine. The day ended with a red, white and blue production blast.

Read more 👉 https://t.co/a2x4zJ1M3I

$GCU $GCUMF $GUNN $AMZN $RIO $COPX $FCX

[RedChip @RedChip]

🧬 Recently on RedChip's Interview Series: Anixa Biosciences (Nasdaq: ANIX) CEO Dr. Amit Kumar discusses the company's breast cancer vaccine program in a new interview, joined by Sherry, a patient who participated in the vaccine's Phase 1 trial.

Dr. Kumar describes the vaccine, developed in partnership with Cleveland Clinic and the U.S. Department of Defense, as designed for three potential uses: treating patients with breast cancer, preventing recurrence in survivors, and primary prevention in patients who have never had the disease. He notes it's a traditional peptide-based vaccine intended for broad use, distinguishing it from personalized mRNA vaccine approaches like the one recently reported in Phase 3 melanoma data from Merck and Moderna. Dr. Kumar states the company's next steps are Phase 2 studies, followed by Phase 3.

📌 What the Interview Covers:
- The vaccine's three intended uses: treatment, recurrence prevention, and primary prevention
- How the peptide-based approach differs from personalized mRNA cancer vaccines
- Planned next steps: Phase 2 studies followed by Phase 3
- Sherry's account of her diagnosis, treatment, and Phase 1 trial participation
- Dr. Kumar's comments on the vaccine's potential longer-term impact on breast cancer treatment

🔗 Watch the full interview: https://t.co/H1KwfEHA0A

Anixa Bioscience is a client of RedChip. Not investment advice. Do your own due diligence.

$MRNA $BNTX $REGN $CRSP $LEGN $RCUS $VIR $NTRA $EXAS $NTLA $EXEL